STRATA Skin Sciences Secures Additional $12 Million Financing with MidCap Financial
July 06, 2023 07:53 ET
|
STRATA Skin Sciences, Inc.
HORSHAM, Pa., July 06, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for...
PDS Biotech Granted Patent for its Novel HPV16 Immunotherapy
January 10, 2022 07:00 ET
|
PDS Biotechnology Corporation
FLORHAM PARK, N.J., Jan. 10, 2022 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies based on the Company’s...
PDS Biotechnology to Present at H.C. Wainwright Bioconnect Virtual Conference
January 05, 2022 08:00 ET
|
PDS Biotechnology Corporation
FLORHAM PARK, N.J., Jan. 05, 2022 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies based on the Company’s...
PDS Biotech Reports An Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
December 23, 2021 16:00 ET
|
PDS Biotechnology Corporation
FLORHAM PARK, N.J., Dec. 23, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease...
PDS Biotech Provides Recruitment update for National Cancer Institute-Led Phase 2 Clinical Trial of PDS0101-Based Combination
December 06, 2021 08:30 ET
|
PDS Biotechnology Corporation
FLORHAM PARK, N.J., Dec. 06, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies based on the Company’s...
PDS Biotechnology Announces Participation in Noble Capital Markets C-Suite Interview Series
May 12, 2021 08:00 ET
|
PDS Biotechnology Corporation
FLORHAM PARK, N.J., May 12, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease...
PDS Biotech Announces Oral Presentation of PDS0101 Data by the National Cancer Institute at 2021 American Society of Clinical Oncology Annual Meeting
April 29, 2021 08:30 ET
|
PDS Biotechnology Corporation
FLORHAM PARK, N.J., April 29, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious...
PDS Biotechnology Announces Conference Call and Webcast for First Quarter Financial Results
April 26, 2021 16:15 ET
|
PDS Biotechnology Corporation
FLORHAM PARK, N.J., April 26, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease...
Alimera Sciences Proposes Public Offering of Common Stock
August 10, 2016 16:01 ET
|
Alimera Sciences, Inc.
ATLANTA, Aug. 10, 2016 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (NASDAQ:ALIM) (Alimera), a pharmaceutical company that specializes in research, development and commercialization of...